Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Pregnancy prevention programme"'
Publikováno v:
Patient Preference and Adherence, Vol Volume 12, Pp 153-161 (2018)
Natacha Biset,1,* Mélanie Lelubre,1–3,* Christelle Senterre,4 Karim Amighi,1 Olivier Bugnon,2,3 Marie P Schneider,2,3 Carine De Vriese1 1Department of Pharmacotherapy and Pharmaceutics, Faculté de Pharmacie, Université libre de Bruxelles (ULB),
Externí odkaz:
https://doaj.org/article/37624bada4bd479fbddfca613ce04431
Publikováno v:
Nasza Dermatologia Online, Vol 9, Iss 4e, Pp e2-e2 (2017)
Background: Oral isotretinoin is the only drug which promotes prolonged remission or cure of severe acne. The aim of our study was to estimate the isotretinoin exposure and to evaluate the effectiveness of the Polish and Romanian pregnancy prevention
Externí odkaz:
https://doaj.org/article/07987b3ee73445cf8384b0f108593df9
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Efstratia Vatzaki, Jean-Michel Dogné, Sabine Straus, Juan Garcia Burgos, Paolo Martelletti, Thomas Girard
Publikováno v:
Vatzaki, E, Straus, S, Dogne, J M, Garcia Burgos, J, Girard, T & Martelletti, P 2018, ' Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age : Overview from European Medicines Agency and European Headache Federation ', Journal of Headache and Pain, vol. 19, no. 1, 6, pp. 68 . https://doi.org/10.1186/s10194-018-0898-3
The Journal of Headache and Pain
The Journal of Headache and Pain, Vol 19, Iss 1, Pp 1-6 (2018)
The Journal of Headache and Pain
The Journal of Headache and Pain, Vol 19, Iss 1, Pp 1-6 (2018)
Migraine is a common and burdensome neurological condition which affects mainly female patients during their childbearing years. Valproate has been widely used for the prophylaxis of migraine attacks and is also included in the main European Guidelin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08d96be74ed892f5f983446356679958
https://pure.unamur.be/ws/files/40366803/DogneJM_EtAl_2018_Article.pdf
https://pure.unamur.be/ws/files/40366803/DogneJM_EtAl_2018_Article.pdf
Autor:
Kari Klungsøyr, Helen Dolk, Marlene Sinclair, V Bettoli, Aurora Puccini, Anders Engeland, Daniel Thayer, Rachel Charlton, H. J. Bos, Anna Pierini, Anne Vinkel Hansen, Amanda J. Neville, L. T. W. De Jong-Van Den Berg, Sue Jordan, Ester Garne, Rosa Gini
Publikováno v:
Charlton, R, Bettoli, V, Bos, H J, Engeland, A, Garne, E, Gini, R, Hansen, A, de Jong-van den Berg, L, Jordan, S, Klungsøyr, K, Neville, A, Pierini, A, Puccini, A, Sinclair, M, Thayer, D & Dolk, H 2018, ' The limitations of some European healthcare databases for monitoring the effectiveness of Pregnancy Prevention Programmes as risk minimisation measures ', European Journal of Clinical Pharmacology, vol. 74, no. 4, pp. 513-520 . https://doi.org/10.1007/s00228-017-2398-9
European Journal of Clinical Pharmacology, 74(4), 513-520. Springer Verlag
Charlton, R A, Bettoli, V, Bos, H J, Engeland, A, Garne, E, Gini, R, Hansen, A V, de Jong-van den Berg, L T W, Jordan, S, Klungsøyr, K, Neville, A J, Pierini, A, Puccini, A, Sinclair, M, Thayer, D & Dolk, H 2018, ' The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures ', European Journal of Clinical Pharmacology, vol. 74, no. 4, pp. 513-520 . https://doi.org/10.1007/s00228-017-2398-9
European Journal of Clinical Pharmacology, 74(4), 513-520. Springer Verlag
Charlton, R A, Bettoli, V, Bos, H J, Engeland, A, Garne, E, Gini, R, Hansen, A V, de Jong-van den Berg, L T W, Jordan, S, Klungsøyr, K, Neville, A J, Pierini, A, Puccini, A, Sinclair, M, Thayer, D & Dolk, H 2018, ' The limitations of some European healthcare databases for monitoring the effectiveness of pregnancy prevention programmes as risk minimisation measures ', European Journal of Clinical Pharmacology, vol. 74, no. 4, pp. 513-520 . https://doi.org/10.1007/s00228-017-2398-9
PURPOSE: Pregnancy prevention programmes (PPPs) exist for some medicines known to be highly teratogenic. It is increasingly recognised that the impact of these risk minimisation measures requires periodic evaluation. This study aimed to assess the ex
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc7eecb3fca4b493a5f31f09237d9798
https://purehost.bath.ac.uk/ws/files/162079700/PPP_Charlton_et_al_PURE.pdf
https://purehost.bath.ac.uk/ws/files/162079700/PPP_Charlton_et_al_PURE.pdf
Autor:
Lelubre, Melanie
Introduction: In recent year, the role of the pharmacist has evolved from product-focused to patient-focused activities. Following this evolution, new professional pharmacy services were simultaneously developed by researchers and started to be legal
Autor:
Marie Paule Schneider, Natacha Biset, Melanie Lelubre, Olivier Bugnon, Carine De Vriese, Karim Amighi, Christelle Senterre
Publikováno v:
Patient Preference and Adherence, 12
Patient preference and adherence, vol. 12, pp. 153-161
Patient preference and adherence
Patient Preference and Adherence, Vol Volume 12, Pp 153-161 (2018)
Patient preference and adherence, vol. 12, pp. 153-161
Patient preference and adherence
Patient Preference and Adherence, Vol Volume 12, Pp 153-161 (2018)
Purpose: The aims of the study were to evaluate medication adherence and the influencing factors for isotretinoin and contraception (oral, patches, and rings) and to evaluate the concomitant use of contraception and isotretinoin. Methods: Reimbursed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a1086f8f2a528f08d540189eae20c35
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/268434
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/268434
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.